摘要
弄虚作假,侵吞国资,高盛造势……?中小板天价发行第一股海普瑞,是大阴谋套小阴谋的赝品,还是被畸形发行制度透支了未来价值的潜力股?"被"加冕"首富"桂冠的李锂,打破上市以来50天的沉默,对《中国企业家》
On May 6th,the IPO of Shenzhen Hepalink Pharmaceutical Co., Ltd opened at the record breaking price of 148 yuan per share,thus making Li Li and his wife Li Ta the richest couple in all of China. Hepalink also twice participated in revising U.S.standards for the drug heparin and has received visits by the head of the U.S.FDA twice. Prior to this,Hepalink's founder Li Li was far from what would be considered a public figure,and most people would never even think about where heparin came from. However with success also comes suspicion,and questions about Hepalink and Li Li form among the public.Now in China Entre-preneurs' exclusive interview with Li Li,he responds to these various questions.
出处
《中国企业家》
2010年第14期86-95,11,共10页
China Entrepreneur